92796-77-5

Basic information

• Product Name: 1,4-Naphthalenedione, 2-[(4-aminophenyl)amino]-3-chloro-
• CAS NO: 92796-77-5
• Molecular Formula: C16H11ClN2O2
• Molecular Weight: 298.729
• Mol File: 92796-77-5.mol
• Article Data: 3

Chemical Properties

• CAS DataBase Reference: 1,4-Naphthalenedione, 2-[(4-aminophenyl)amino]-3-chloro-(CAS DataBase Reference)
• NIST Chemistry Reference: 1,4-Naphthalenedione, 2-[(4-aminophenyl)amino]-3-chloro-(92796-77-5)
• EPA Substance Registry System: 1,4-Naphthalenedione, 2-[(4-aminophenyl)amino]-3-chloro-(92796-77-5)

Safety Data

• Hazardous Substances Data: 92796-77-5(Hazardous Substances Data)

Upstream product

• 90-15-3 α-naphthol 
• 117-80-6 2,3-Dichloro-1,4-naphthoquinone 
• 106-50-3 1,4-phenylenediamine 

Downstream Products

• 465547-58-4 N-4-((3-pyrrolidino-1,4-naphthalenedion-2-yl)amino)phenyl-O-methylcarbamate 
• 465547-45-9 2-(N-4-aminobenzoylanilino)-3-pyrrolidino-1,4-naphthoquinone 

Relevant articles and documents

COMPOUNDS AND PHARMACEUTICAL COMPOSITION ASSOCIATED WITH UBIQUITINATION-PROTEASOME SYSTEM

The invention relates to new compounds with low cytotoxicity for blocking ubiquitination-proteasome system in diseases. Accordingly, these compounds can be used in treatment of treating disorders including, but not limited to, cancers, neurodegenerative d

Identification of compounds for the treatment or prevention of proliferative diseases

The invention features screening assays for compounds that are potentially useful for treating or preventing a proliferative disease. The assays are based on contacting a candidate compound with a cell containing a nucleic acid including a HER2 regulatory element and a reporter sequence. In addition, the invention features compounds identified by the assays of the invention. The invention further features compounds structurally related to those identified by the screening assays. Finally, the invention features methods of treating or preventing a proliferative disease using the compounds of the invention.